Results 111 to 120 of about 1,725 (146)

Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trial. [PDF]

J Antimicrob Chemother
Jo J, Carlson TJ, Hu C, Williamson JC, Belin YT, Horvath TD, Haidacher SJ, Bassères E, Begum K, Alam MJ, Garey KW.   +10 more
europepmc   +1 more source

Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>. [PDF]

Infect Drug Resist
Chen D, Lan H, Yang W, Tian D, Liu Y, Ju L, Song Q, Min R, Wang Y, Li Y, Wang P, Cao J.   +11 more
europepmc   +1 more source

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018

, 2020
Michael A. Pfaller, Michael D. Huband, Dee Shortridge, Robert K. Flamm   +3 more
openalex   +2 more sources

Clinical Features and Treatment Differences Among Tuberculous, Brucellosis, and Pyogenic Spondylitis: A Cohort Study. [PDF]

Infect Drug Resist
Shen JJ, Yao RX, Ye Y, Gao YF, Li JB, Hu LF.   +5 more
europepmc   +1 more source

The Evolution of Virulence of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> from the Same Source Under the Pressure of Omadacycline Treatment. [PDF]

Infect Drug Resist
Fang J, Liu Q, Chen H, Lai H, Huang J, Li J, Xu Y, Cheng N, Xiang T.   +8 more
europepmc   +1 more source

A case of psittacosis pneumonia complicated by rhabdomyolysis. [PDF]

World J Emerg Med
Zhu Z, Li H, Bi S, Xiao Y.
europepmc   +1 more source

P-411. Activity of Omadacycline Against 35,000 Bacterial Clinical Isolates and Resistant Organism Subsets from Patients in the United States (2019–2023)

Michael D. Huband, Kelley A. Fedler, Kelly Wright, Rodrigo E. Mendes, Mariana Castanheira   +4 more
openalex   +1 more source

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]

Front Microbiol
Frontiers Production Office.
europepmc   +1 more source

In vitro Activity of the Novel Tetracyclines Derivative, Zifanocycline Against <i>Mycobacterium abscessus</i>. [PDF]

Infect Drug Resist
Yu Q, Niu X, Hou B, Mao M, Zhu L, Shen W, Wang W.   +6 more
europepmc   +1 more source

Development, validation, and clinical application of a UPLC-MS/MS method for omadacycline determination in human serum

Guo Suhang, Zheng Ren, Fan Xudong, Zhang Ruoying, Xinjun Cai, Jie Jin   +5 more
openalex   +1 more source